ELZANOR TXR 25/5/1000MG TAB

ELZANOR TXR is a triple-action tablet combining empagliflozin, linagliptin, and metformin HCl in a 25/5/1000mg formulation. This combination medication is designed to help manage type 2 diabetes by working through multiple mechanisms—improving insulin sensitivity, enhancing glucose excretion, and regulating blood sugar levels. The extended-release formulation ensures consistent therapeutic effect throughout the day. Suitable for patients requiring comprehensive glycemic control, ELZANOR TXR offers the convenience of a single tablet containing three active ingredients. Always use as directed by your healthcare provider.